Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $334.98M | $301.67M | $281.27M | $265.20M | $232.09M | $203.47M | $201.81M | $191.48M |
| Cost of revenue | $115.95M | $104.92M | $99.49M | $93.59M | $81.21M | $74.72M | $77.59M | $74.49M |
| Gross profit | $219.03M | $196.75M | $181.77M | $171.61M | $150.88M | $128.75M | $124.22M | $116.99M |
| Gross margin | 65.4% | 65.2% | 64.6% | 64.7% | 65.0% | 63.3% | 61.6% | 61.1% |
| Research and development | $96.53M | $91.04M | $98.26M | $89.96M | $87.45M | $88.52M | $93.54M | $87.31M |
| Selling, general and administrative | $251.61M | $227.06M | $204.32M | $180.64M | $169.85M | $151.27M | $156.64M | $147.01M |
| Operating expenses | $348.15M | $318.10M | $302.58M | $270.60M | $257.30M | $239.79M | $250.19M | $234.32M |
| Operating income | −$129.12M | −$121.35M | −$120.81M | −$98.99M | −$106.41M | −$111.04M | −$125.97M | −$117.33M |
| Operating margin | -38.5% | -40.2% | -43.0% | -37.3% | -45.9% | -54.6% | -62.4% | -61.3% |
| EBITDA | −$119.56M | −$111.91M | −$110.76M | −$89.58M | −$96.37M | −$100.81M | −$115.51M | −$106.73M |
| Interest income | $10.20M | $11.15M | $10.03M | $7.39M | $7.56M | $9.11M | $11.65M | $13.26M |
| Interest expense | −$1.35M | −$1.35M | −$1.18M | −$943.00K | −$983.00K | −$791.00K | −$645.00K | −$646.00K |
| Income before taxes | −$119.96M | −$111.70M | −$130.22M | −$92.59M | −$99.86M | −$94.87M | −$110.29M | −$107.72M |
| Income taxes | $185.00K | $372.00K | −$1.73M | $136.00K | $38.00K | $290.00K | $716.00K | $30.00K |
| Net income | −$120.14M | −$112.08M | −$128.49M | −$92.73M | −$99.90M | −$95.16M | −$111.01M | −$107.75M |
| Net margin | -35.9% | -37.2% | -45.7% | -35.0% | -43.0% | -46.8% | -55.0% | -56.3% |
| EPS, basic | −$0.90 | −$0.85 | −$1.00 | −$0.74 | −$0.80 | −$0.77 | −$0.90 | −$0.88 |
| EPS, diluted | −$0.90 | −$0.85 | −$1.00 | −$0.74 | −$0.80 | −$0.77 | −$0.90 | −$0.88 |
| Diluted shares | 132.87M | 131.27M | 128.70M | 124.81M | 124.11M | 123.87M | 123.77M | 123.05M |
Figures describe Guardant Health shares, not any token. As of Jul 30, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.